SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Director/PDMR Shareholding

1 Jul 2015 16:04

RNS Number : 9069R
Consort Medical PLC
01 July 2015
 



 

 

Consort Medical plc

Director/PDMR shareholding

1 July 2015

Consort Medical plc announces that the undermentioned directors and other persons discharging managerial responsibilities, ('PDMRs'), have exercised awards/options granted under the terms of the Consort Medical Long-Term Incentive Plan ('LTIP') and/or the Consort Medical plc Company Share Option Plan 2010 ('CSOP') and sold shares as set out below. 

LTIP awards granted on 19 June 2012 to Mr Glenn, Ms King and Mr Djamarani vested on 19 June 2015. LTIP awards and CSOP options granted on 25 June 2012 to Mr Cotton vested on 25 June 2015. 

The exercise of the awards/option was satisfied out of ordinary shares held by the trustee of the Consort Medical plc Employee Share Ownership Trust.

The exercise of awards/option and disposals of shares referred to below took place on 26 June 2015 at £9.1275 per share: the Company was informed of the transactions by the trustee of the Consort Medical plc Employee Share Ownership Trust on 30 June 2015. Shares acquired pursuant to LTIP awards are acquired for nil consideration. Shares acquired pursuant to the CSOP option were acquired for an exercise price of £5.7117 per share.

Individual

Director /PDMR

LTIP Awards - Aggregate number of Shares

CSOP Option - Aggregate number of Shares

Shares sold

Shares retained

Total shares held following the event

% of share capital

Jonathan Glenn

Director

75,340

 

35,410

39,930

145,119*

0.30%

Richard Cotton

Director

44,380

 

5,252

24,146

25,486

49,283

0.10%

Lisa King

PDMR

26,529

 

22,792

0

10,376

0.02%

Keyvan Djamarani

PDMR

22,226

 

22,226

0

18,503

0.04%

 

All of the shares sold by Mr Glenn (35,410) were sold to cover tax liabilities. All of the shares sold by Mr Cotton (24,146) were sold to cover tax liabilities and the exercise price payable in respect of the CSOP Option.

* Mr Glenn's shareholding is inclusive of shares acquired pursuant to Deferred Bonus Plan award exercised on the same date.

Enquiries: I Ward, Company Secretary 01442 867920

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEFLFBEDFBBBL
Date   Source Headline
15th Jun 20123:12 pmRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSDirectorate
14th Jun 20127:00 amRNSPreliminary Results
6th Jun 20121:57 pmRNSBlocklisting Interim Review
1st May 201210:21 amRNSTotal Voting Rights
30th Apr 20127:00 amRNSFDA Approval Proprietary Integrated Dose Counter
20th Apr 201210:54 amRNSHolding(s) in Company
16th Apr 201211:37 amRNSBlocklisting Interim Review
28th Mar 20124:36 pmRNSHolding(s) in Company
22nd Mar 20129:58 amRNSAnnual Information Update
20th Mar 20124:25 pmRNSReplacement Interim Management Statement
20th Mar 20121:07 pmRNSInterim Management Statement
1st Mar 20129:00 amRNSTotal Voting Rights
17th Feb 201210:09 amRNSHolding(s) in Company
23rd Jan 20129:45 amRNSBlocklisting Interim Review
13th Dec 20112:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20111:34 pmRNSBlocklisting Interim Review
1st Dec 20117:00 amRNSInterim results for the six months ended 31/10/11
19th Oct 20114:03 pmRNSHolding(s) in Company
17th Oct 20113:13 pmRNSHolding(s) in Company
14th Oct 20119:39 amRNSBlocklisting Interim Review
7th Oct 201112:13 pmRNSHolding(s) in Company
5th Oct 20114:47 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSSecond Nasal Drug Delivery Contract
27th Sep 20114:33 pmRNSHolding(s) in Company
26th Sep 20113:01 pmRNSHolding(s) in Company
2nd Sep 201110:21 amRNSTotal Voting Rights
1st Sep 20112:50 pmRNSResult of AGM
1st Sep 20112:47 pmRNSDirectorate Change
1st Sep 201112:40 pmRNSInterim Management Statement
1st Sep 20117:00 amRNSNasal Drug Delivery Contract
24th Aug 20114:35 pmRNSHolding(s) in Company
2nd Aug 20111:51 pmRNSDirector/PDMR Shareholding
2nd Aug 20111:47 pmRNSDirector/PDMR Shareholding
28th Jul 20119:14 amRNSAnnual Financial Report
20th Jul 20117:00 amRNSFurther re Investment in Atlas Genetics
30th Jun 20111:58 pmRNSTotal Voting Rights
24th Jun 20119:06 amRNSHolding(s) in Company
21st Jun 201112:33 pmRNSBlocklisting Interim Review
16th Jun 20117:00 amRNSPreliminary results for the year ended 30/04/11
2nd Jun 20117:00 amRNSBlocklisting Interim Review
10th May 20119:27 amRNSHolding(s) in Company
14th Apr 201110:20 amRNSBlocklisting Interim Review
4th Apr 201110:29 amRNSHolding(s) in Company
1st Apr 20111:51 pmRNSHolding(s) in Company
23rd Mar 20112:04 pmRNSAnnual Information Update
14th Mar 20117:00 amRNSInterim Management Statement
15th Feb 20114:14 pmRNSHolding(s) in Company
9th Feb 201111:15 amRNSDirectorate Change
7th Feb 20117:00 amRNSPartners with Atlas Genetics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.